A team in Pittsburgh received a $2.3 million grant to fast-track the development and clinical transition of a minimally ...

Wireless brain sensor aims to prevent failures, giving hydrocephalus patients early alerts before symptoms become critical.

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients ...

The global hydrocephalus shunt market is poised for steady expansion, with Future Market Insights (FMI) projecting a market ...

CereVasc, Inc. announced the initial results of its United States pilot clinical study of the CereVasc eShunt system in the ...

The pediatric patient and mother aboard the Jet Rescue Air Ambulance that crashed and exploded in Northeast Philadelphia have ...

Without treatment, bipolar disorder may cause mood episodes. People may alternate between high periods, known as manic episodes, and low periods, or depressive episodes. During a manic episode ...

Hydrogen peroxide might sound like an alternative to traditional cancer treatments, but it hasn’t been shown to treat or cure cancer in humans and can be dangerous when taken internally.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

Pritelivir mesylate is under clinical development by AiCuris Anti-infective Cures and currently in Phase III for Simplexvirus (HSV) Infections. According to GlobalData, Phase III drugs for ...